FIELD: pharmaceutics.
SUBSTANCE: invention relates to crystalline forms and salt crystalline forms of the pyrazolopyridine compound presented below.
EFFECT: novel crystalline forms of said compound are obtained, which can be used in medicine to produce a drug for influenza virus.
83 cl, 36 dwg, 22 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE FORMS OF GRAPIPRANT | 2015 |
|
RU2638931C1 |
| CRYSTALLINE AND SALT FORMS OF THE TGF-βR1 INHIBITOR AND THE METHOD OF OBTAINING THEM | 2018 |
|
RU2750702C1 |
| COMPOUND OF BRD4 INHIBITOR IN SOLID FORM, METHOD FOR ITS PRODUCTION AND APPLICATION | 2020 |
|
RU2793346C1 |
| HYDROCHLORIDE FORM OF INHIBITOR OF DIPEPTIDYLPEPTIDASE IV AND METHOD OF PRODUCING SALT FORM | 2017 |
|
RU2734549C2 |
| 11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZATETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE CITRATE | 2009 |
|
RU2527970C2 |
| CRYSTALLINE FORM A OF COMPOUND AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2699030C2 |
| CRYSTALLINE FORM OF THE COMPOUND CONSTITUTING A PRODRUG OF LANOSTEROL, AND APPLICATION THEREOF IN MANUFACTURE OF A MEDICINAL PRODUCT FOR TREATING CATARACTS | 2019 |
|
RU2766088C1 |
| COMPOUND OF FGFR INHIBITOR IN SOLID FORM AND METHOD OF ITS PREPARATION | 2020 |
|
RU2810067C2 |
| POLYMORPH MALEATE OF DIPEPTIDYL PEPTIDASE INHIBITOR IV (DPPIV) AND A METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2732577C1 |
| METHOD OF PURIFYING A BENZOPYRAN DERIVATIVE, ITS CRYSTALLINE FORM AND A METHOD OF PRODUCING A CRYSTALLINE FORM | 2016 |
|
RU2729074C2 |
